Drugs / V441
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00092469 | Mar 2002 → Aug 2003 | diphtheria, hepatitis B virus infection, pertussis, poliomyelitis +1 | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V441 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00092469 ↗ |
| Modality | Vaccine | “investigational vaccine being evaluated to reduce the incidence of diphtheria, pertussis, tetanus, hepatitis B, poliomyelitis, and Haemophilus influenza type b” NCT00092469 ↗ |